Advisor Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $11K | Hold |
186
| – | – | ﹤0.01% | 4301 |
|
|
2019
Q3 | $11K | Sell |
186
-61
| -25% | -$3.61K | ﹤0.01% | 4291 |
|
|
2019
Q2 | $14K | Hold |
247
| – | – | ﹤0.01% | 4187 |
|
|
2019
Q1 | $12K | Sell |
247
-79
| -24% | -$3.84K | ﹤0.01% | 4281 |
|
|
2018
Q4 | $13K | Buy |
326
+117
| +56% | +$4.67K | ﹤0.01% | 4065 |
|
|
2018
Q3 | $14K | Buy |
209
+41
| +24% | +$2.75K | ﹤0.01% | 4095 |
|
|
2018
Q2 | $13K | Buy |
168
+100
| +147% | +$7.74K | ﹤0.01% | 3948 |
|
|
2018
Q1 | $4K | Buy |
+68
| New | +$4K | ﹤0.01% | 4505 |
|
|
2017
Q4 | – | Sell |
-27
| Closed | -$2K | – | 5072 |
|
|
2017
Q3 | $2K | Sell |
27
-273
| -91% | -$20.2K | ﹤0.01% | 4581 |
|
|
2017
Q2 | $24K | Hold |
300
| – | – | ﹤0.01% | 3392 |
|
|
2017
Q1 | $25K | Sell |
300
-300
| -50% | -$25K | ﹤0.01% | 3235 |
|
|
2016
Q4 | $48K | Hold |
600
| – | – | ﹤0.01% | 2645 |
|
|
2016
Q3 | $42K | Hold |
600
| – | – | ﹤0.01% | 2666 |
|
|
2016
Q2 | $23K | Buy |
+600
| New | +$23K | ﹤0.01% | 2979 |
|